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The wide variety of bone tissue engineering applications ranges from reconstruction 
of long bone defects in the femour, articular osteochondral defects to craniofacial recon-
struction. Sources of cells in bone tissue engineering include Mesenchymal Stem Cells 
(MSCs). The most important supply of cells for bone repair seems to be bone itself. Bone 
and bone marrow (BM) could be therefore considered the main local source of skeletal 
stem cells/progenitors. More recently, periosteal progenitor cells (PCs), mesenchymal 
stem cells derived from amniotic fluid (AF-MSCs) and from skin (S-MSCs) have been 
suggested for bone tissue-engineering applications. In the present research the ability of 
stem cells isolated from bone marrow (BM-MSCs) and subchondral bone (B-MSCs), PCs, 
AF-MSCs and S-MSCs to differentiate in osteocytes and chondrocyte were evaluated. 
Before differentiation, cell phenotype was assessed in agreement with the Interna-
tional Society for Cellular Therapy guidelines.Cell differentiation towards osteoblastic 
and chondroblastic phenotypes was performed in the appropriate medium and evalu-
ated with alkaline phosphatase and von Kossa stainings for osteoblasts and Alcian Blue 
staining for chondroblasts
As expected, BM-MSCs and B-MSCs differentiate either in osteoblasts or in chond-
roblasts. Osteoblastic differentiation was observed also in AF-MSCs, S-MSCs and PCs.
Our results suggest that differently-derived adult stem cells could represent an in-
teresting aid to produced engineered tissue for a rapid clinical use. Moreover, the use 
of different stem cell sources may identify explicit tissue engineering approaches: for 
instance, the use of bone derived progenitors cells (i.e. B-MSCs and PCs), whose har-
vesting is more invasive, may be restricted to strategies forecasting their recruitment in 
the lesion site, while S-MSC (most abundant) may be utilized in those tissue engineering 
applications in which a large cell amount is needed.
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